Elon Musk recently posted a photo on social media showcasing his weight loss using the anti-obesity drug Ozempic (Mounjaro). This comes as public figures increasingly open up about their use of such medications. The popularity of GLP-1 agonists among celebrities has driven shortages, highlighting the need for increased access to these life-changing treatments.
The Biden administration recently proposed a rule requiring Medicare and Medicaid coverage for anti-obesity drugs like Ozempic, which could improve health outcomes and lifespan for millions of Americans struggling with obesity. However, this move is opposed by some, including Robert F. Kennedy Jr.
Musk’s support for increased access to these medications underscores the need for lower costs to make them more affordable for the general public. The proposed rule aims to expand coverage for GLP-1 agonists, which have been hailed as game-changers in addressing the obesity crisis linked to chronic diseases.
Source: https://www.axios.com/2024/12/26/elon-musk-ozempic-mounjaro-weight-loss